This is a routine governance filing with no financial or strategic content. No trading action is warranted; monitor future filings for operating updates or pipeline developments.
Price Chart
Executive Summary
Nymox Pharmaceutical Corp filed a 6-K reporting the results of a special shareholder meeting held on August 28, 2026, where the board of directors was re-elected. The filing is routine — no material financial data, no business changes, and no strategic updates were disclosed.
Key Facts
- 105,040,140 total shares issued and outstanding
- 47,885,624 shares (45.59%) were voted
- 47,066,029 shares (98.29%) voted in favor of director nominees
- 819,595 shares (1.71%) withheld/abstained
- Board members re-elected: Dr. Paul Averback (Chair), Dr. David Morse, Dr. Russell Thomson, Dr. Kresimir Pucaj, Robert Lachance
- Meeting conducted virtually — no other business was entertained
Financial Impact
No financial figures reported; no impact on revenue, earnings, or cash position.
Risk Factors
- Low shareholder turnout (45.59%) may indicate limited retail engagement, but no immediate risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001640334-26-001427 |
| Document: nymox_ex991.htm | 0001640334-26-001427 |
| Document: 0001640334-26-001427-index-headers.html | 0001640334-26-001427 |
| Document: 0001640334-26-001427-index.html | 0001640334-26-001427 |
| Document: 0001640334-26-001427.txt | 0001640334-26-001427 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 6w ago | 20-F | $0.000200 $0.000200 | · 0.00% | ▼ −0.46% | $0.0410 (−20400.00%) |
Aug 31, 2026 8w ago | 6-K | $0.000200 $0.000200 | · 0.00% | ▲ +0.69% | $0.0410 (+20400.00%) |
Aug 7, 2026 11w ago | 6-K | $0.000200 $0.000200 | · 0.00% | ▲ +0.03% | $0.0410 (+20400.00%) |
Jun 3, 2026 20w ago | 6-K | $0.1269 $0.0646 | ▲ +49.09% | ▲ +49.50% | $0.0410 (+67.69%) |
Mar 27, 2026 30w ago | 6-K | $0.0705 $0.0700 | ▼ −0.71% | ▼ −3.60% | $0.0410 (−41.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers